Watchlist Price Alert

Alnylam Pharmaceuticals I... (ALNY)

NASDAQ: ALNY · Real-Time Price · USD

307.73

-1.05 (-0.34%)

At close: Jun 17, 2025, 12:49 PM

Alnylam Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-278.16M	-440.24M	-1.13B	-852.82M	-858.28M	-886.12M	-761.5M	-490.87M	-410.11M
Depreciation & Amortization	56.67M	97.03M	85.55M	89.69M	74.44M	54.37M	6.43M	13.37M	15.13M
Stock-Based Compensation	272.08M	221.68M	230.65M	165.72M	139.87M	174.84M	157.75M	92.82M	75.53M
Other Working Capital	n/a	-509K	-147.59M	-122.85M	-38.41M	422.42M	37.02M	1.85M	16.76M
Other Non-Cash Items	47.85M	214.93M	309.24M	174.24M	95.75M	-12.61M	-6.84M	2.91M	1.51M
Deferred Income Tax	-106.76M	n/a	n/a	-55.7M	-54.04M	-11.29M	-3.56M	1.89M	-6.98M
Change in Working Capital	n/a	10.76M	-35.55M	-162.82M	-12.7M	402.38M	45.1M	-2.9M	17.22M
Operating Cash Flow	-8.31M	104.16M	-541.27M	-641.69M	-614.96M	-278.43M	-562.62M	-382.79M	-307.7M
Capital Expenditures	-34.28M	-62.21M	-72.06M	-76.37M	-70.36M	-140.16M	-126.89M	-104.21M	-64.56M
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-1.71B	-1.82B	-1.98B	-1.66B	-2.03B	-2.08B	-1.1B	-903.46M	-759.31M
Sales Maturities Of Investments	1.57B	1.55B	2.23B	1.46B	1.69B	1.78B	1.52B	597.3M	1.12B
Other Investing Acitivies	57.76M	-4.44M	-13.19M	-4.36M	-31.2M	23M	-14.82M	120M	-150M
Investing Cash Flow	-116.84M	-336.35M	169.35M	-273.3M	-435.52M	-417.68M	272.94M	-290.36M	142.59M
Debt Repayment	n/a	n/a	254M	500M	200M	n/a	n/a	-120M	150M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	-3.47M	-257K	-596K
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	294.16M	172.13M	171.75M	747.12M	695.48M	41.28M	65.47M	83.89M	14.13M
Financial Cash Flow	294.16M	172.13M	425.75M	1.25B	994.98M	823.18M	65.47M	1.12B	177.83M
Net Cash Flow	153.77M	-53.67M	46.4M	323.11M	-50.58M	127M	-224.2M	451.74M	12.72M
Free Cash Flow	-42.59M	41.95M	-613.33M	-718.07M	-685.32M	-418.58M	-689.5M	-487M	-372.26M